Disclosed herein are pharmaceutical compositions comprising combinations
of tolterodine, an antimuscarinic agent, and pilocarpine, a compound that
causes stimulation of salivary glands. Also disclosed are methods of
treating a patient suffering from overactive bladder comprising
administering to the patient said pharmaceutical composition.